3/26
04:15 pm
ivvd
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
Low
Report
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
3/26
08:19 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/20
03:36 pm
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Low
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
3/20
08:32 am
ivvd
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]
Low
Report
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]
3/20
08:01 am
ivvd
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
Medium
Report
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
3/5
08:11 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Medium
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
3/5
07:05 am
ivvd
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
Low
Report
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
2/28
08:02 pm
ivvd
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart) [Yahoo! Finance]
High
Report
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart) [Yahoo! Finance]
2/28
08:02 pm
ivvd
Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™ [Yahoo! Finance]
High
Report
Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™ [Yahoo! Finance]
2/28
08:02 pm
ivvd
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024 [Yahoo! Finance]
High
Report
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024 [Yahoo! Finance]
2/28
02:06 pm
ivvd
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 [Yahoo! Finance]
Medium
Report
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 [Yahoo! Finance]
2/27
09:58 am
ivvd
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to Med
Low
Report
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to Med
2/26
06:28 am
ivvd
Chargers' Jim Harbaugh loves seeing NFL stars being open about their faith: 'It's inspiring' [FOX News]
Medium
Report
Chargers' Jim Harbaugh loves seeing NFL stars being open about their faith: 'It's inspiring' [FOX News]
2/25
06:54 pm
ivvd
Chargers' Jim Harbaugh on controversial tush push: 'Get good at it or stop it' [FOX News]
Low
Report
Chargers' Jim Harbaugh on controversial tush push: 'Get good at it or stop it' [FOX News]
2/25
04:54 pm
ivvd
Jim Harbaugh On Los Angeles Chargers’ Objective Entering 2025 Season: ‘Win The Day’ [Forbes]
Low
Report
Jim Harbaugh On Los Angeles Chargers’ Objective Entering 2025 Season: ‘Win The Day’ [Forbes]
2/24
12:19 pm
ivvd
5 Stocks That More Than Doubled Halfway Through Q1 [Yahoo! Finance]
High
Report
5 Stocks That More Than Doubled Halfway Through Q1 [Yahoo! Finance]
2/24
11:32 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
High
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
2/24
08:16 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Low
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
2/24
07:05 am
ivvd
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing
High
Report
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing
2/23
02:00 pm
ivvd
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far [Yahoo! Finance]
High
Report
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far [Yahoo! Finance]
2/10
07:18 am
ivvd
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 [Yahoo! Finance]
High
Report
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 [Yahoo! Finance]
2/10
07:00 am
ivvd
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025
High
Report
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025
2/5
10:10 am
ivvd
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold [Yahoo! Finance]
High
Report
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold [Yahoo! Finance]
2/5
09:30 am
ivvd
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold
High
Report
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold
2/4
08:00 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.